Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis

PurposeWe aimed to identify the clinical predictors of incidental prostate cancer (IPCa) after surgery for presumed benign prostatic hyperplasia (BPH).MethodsThe literature was comprehensively searched using PubMed, Web of Science, Embase, and Cochrane databases in December 2024. We used pooled stan...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Wang, Xiancheng Li, Hua Yang, Chaoshan Yin, Yameng Wu, Xiaoke Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1561675/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850230487505698816
author Yang Wang
Xiancheng Li
Hua Yang
Chaoshan Yin
Yameng Wu
Xiaoke Chen
author_facet Yang Wang
Xiancheng Li
Hua Yang
Chaoshan Yin
Yameng Wu
Xiaoke Chen
author_sort Yang Wang
collection DOAJ
description PurposeWe aimed to identify the clinical predictors of incidental prostate cancer (IPCa) after surgery for presumed benign prostatic hyperplasia (BPH).MethodsThe literature was comprehensively searched using PubMed, Web of Science, Embase, and Cochrane databases in December 2024. We used pooled standardized mean difference (SMD) and odds ratio (OR) to describe the correlation between relevant risk factors and IPCa.ResultsTwenty-one studies included 10,842 patients that were available for further analysis. After BPH surgery, 957 patients were histopathologically diagnosed with IPCa. The IPCa rate was 8.83%. Most importantly, our results identified that IPCa was significantly associated with age (pooled SMD = 0.36, P < 0.001), body mass index (BMI) (pooled SMD = 0.23, P < 0.001), preoperative prostate-specific antigen (pre-PSA) (pooled SMD = 0.43, P < 0.001), preoperative prostate-specific antigen density (pre-PSAD) (pooled SMD = 0.62, P = 0.028), resected prostate weight (pooled SMD = -0.22, P < 0.001), preoperative treatment with 5-alpha reductase inhibitors (5αRIs) (yes/no) (pooled OR = 0.60, P < 0.001), family history (yes/no) (pooled OR = 3.81, P = 0.029), digital rectal examination (DRE) findings (abnormal/normal) (pooled OR = 5.15, P < 0.001), and transrectal ultrasonography (TRUS) findings (abnormal/normal) (pooled OR = 2.92, P < 0.001). Additionally, sensitivity and subgroup analyses indicated that our findings were reliable and robust. However, we found no significant associations between IPCa and prostate volume, preoperative negative prostate biopsy, smoking history, history of hypertension, history of diabetes, history of dyslipidemia, and abnormal magnetic resonance imaging findings (all P > 0.05).ConclusionsAge, BMI, pre-PSA, pre-PSAD, resected prostate weight, preoperative treatment with 5αRIs, family history, abnormal DRE findings, and abnormal TRUS findings are independent factors predicting IPCa following BPH surgery. Before BPH surgery, factors such as age, BMI, pre-PSA, and pre-PSAD should be considered to assess the risk of IPCa. For high-risk patients, more detailed imaging and needle biopsy are recommended before surgery to avoid missed diagnosis. In the future, more large-scale and well-designed studies are needed to validate our results further.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42025631346.
format Article
id doaj-art-c937864c4e6b4319ae3228d22e202231
institution OA Journals
issn 2234-943X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-c937864c4e6b4319ae3228d22e2022312025-08-20T02:03:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-02-011510.3389/fonc.2025.15616751561675Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysisYang Wang0Xiancheng Li1Hua Yang2Chaoshan Yin3Yameng Wu4Xiaoke Chen5Department of Urology, Guangdong Provincial People’s Hospital, Zhuhai Hospital (Jinwan Central Hospital of Zhuhai), Zhuhai, ChinaDepartment of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Urology, Renmin Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Urology, Fuyang Hospital of Anhui Medical University, Fuyang, ChinaDepartment of Urology, Fuyang Hospital of Anhui Medical University, Fuyang, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Zhuhai Hospital (Jinwan Central Hospital of Zhuhai), Zhuhai, ChinaPurposeWe aimed to identify the clinical predictors of incidental prostate cancer (IPCa) after surgery for presumed benign prostatic hyperplasia (BPH).MethodsThe literature was comprehensively searched using PubMed, Web of Science, Embase, and Cochrane databases in December 2024. We used pooled standardized mean difference (SMD) and odds ratio (OR) to describe the correlation between relevant risk factors and IPCa.ResultsTwenty-one studies included 10,842 patients that were available for further analysis. After BPH surgery, 957 patients were histopathologically diagnosed with IPCa. The IPCa rate was 8.83%. Most importantly, our results identified that IPCa was significantly associated with age (pooled SMD = 0.36, P < 0.001), body mass index (BMI) (pooled SMD = 0.23, P < 0.001), preoperative prostate-specific antigen (pre-PSA) (pooled SMD = 0.43, P < 0.001), preoperative prostate-specific antigen density (pre-PSAD) (pooled SMD = 0.62, P = 0.028), resected prostate weight (pooled SMD = -0.22, P < 0.001), preoperative treatment with 5-alpha reductase inhibitors (5αRIs) (yes/no) (pooled OR = 0.60, P < 0.001), family history (yes/no) (pooled OR = 3.81, P = 0.029), digital rectal examination (DRE) findings (abnormal/normal) (pooled OR = 5.15, P < 0.001), and transrectal ultrasonography (TRUS) findings (abnormal/normal) (pooled OR = 2.92, P < 0.001). Additionally, sensitivity and subgroup analyses indicated that our findings were reliable and robust. However, we found no significant associations between IPCa and prostate volume, preoperative negative prostate biopsy, smoking history, history of hypertension, history of diabetes, history of dyslipidemia, and abnormal magnetic resonance imaging findings (all P > 0.05).ConclusionsAge, BMI, pre-PSA, pre-PSAD, resected prostate weight, preoperative treatment with 5αRIs, family history, abnormal DRE findings, and abnormal TRUS findings are independent factors predicting IPCa following BPH surgery. Before BPH surgery, factors such as age, BMI, pre-PSA, and pre-PSAD should be considered to assess the risk of IPCa. For high-risk patients, more detailed imaging and needle biopsy are recommended before surgery to avoid missed diagnosis. In the future, more large-scale and well-designed studies are needed to validate our results further.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42025631346.https://www.frontiersin.org/articles/10.3389/fonc.2025.1561675/fullincidental prostate cancerbenign prostatic hyperplasiameta-analysisrisk factorssurgery
spellingShingle Yang Wang
Xiancheng Li
Hua Yang
Chaoshan Yin
Yameng Wu
Xiaoke Chen
Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
Frontiers in Oncology
incidental prostate cancer
benign prostatic hyperplasia
meta-analysis
risk factors
surgery
title Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
title_full Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
title_fullStr Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
title_full_unstemmed Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
title_short Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
title_sort predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia an updated systematic review and meta analysis
topic incidental prostate cancer
benign prostatic hyperplasia
meta-analysis
risk factors
surgery
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1561675/full
work_keys_str_mv AT yangwang predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis
AT xianchengli predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis
AT huayang predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis
AT chaoshanyin predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis
AT yamengwu predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis
AT xiaokechen predictivefactorsofincidentalprostatecancerinpatientsundergoingsurgeryforpresumedbenignprostatichyperplasiaanupdatedsystematicreviewandmetaanalysis